Answers are grounded in this paper and cite their sources.
In vitro analysis reveals optimized antifungal effects in mucoadhesive gel for oral candidiasis treatment, indicating therapeutic benefits.
The mucoadhesive gel containing NYS:βCD optimized both antifungal activity without compromising its rheological, mucoadhesive properties, and cytocompatibility at lower therapeutic doses compared to noncomplexed NYS. These findings suggest significant advantages for the treatment of oral candidiasis.
No takes yet. Share an insight, caveat, or question.
Sugio et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: